GlaxoSmithKline (GSK) has accelerated the review of its Horlicks business in India, hoping to sell it for over $4 billion and potentially use the cash for Novartis' buy out deal. Bloomberg ...

GlaxoSmithKline is to sell off its famous bedtime malted milk drink Horlicks in the UK, and will also consider exiting a pharma business, its cephalosporins antibiotics franchise.

GlaxoSmithKline’s brand of Horlicks recently launched an initiative – ‘Horlicks Smart Pass’ which is aimed at students preparing to sit for the Grade 5 Scholarship examination. The company said the ...